This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Testing a combination therapy with Ras-ERK and mTor inhibitors for L-DOPA induced dyskinesia Investments < €500k United Kingdom 2016
Are astrocytes required for optimal survival of ES cell-derived dopaminergic transplants? Investments < €500k United Kingdom 2016
Whole genome methylomic profiling in Parkinson’s: An integrated genetic-epigenetic approach Investments < €500k United Kingdom 2016
Determining the impact of a designated multidisciplinary care centre in Cambridge on the natural history of Motor Neurone Disease Investments < €500k United Kingdom 2016
Delivering personalised synthetic voices for patients with MND Investments < €500k United Kingdom 2016
Practical management of cognitive and neuropsychiatric symptoms in MND – development of the MiNDToolkit Investments < €500k United Kingdom 2016
Efficacy and safety of low-dose IL-2 (Id-IL-2) as a Treg enhancer for controlling neuro-inflammation in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients (MIROCALS) Investments < €500k United Kingdom 2016
A longitudinal study of the evolution of language changes in Motor Neuron Disease (MND): Neuropsychology and Neuroimaging correlates of Language performance in MND Investments < €500k United Kingdom 2016
Population based genotype-phenotype correlation to stratify incident cases of patients with motor neurone disease in Scotland from 2015-2017 Investments < €500k United Kingdom 2016
DeNDRoN MND Co-ordinator Investments < €500k United Kingdom 2016
